• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
INK128

INK128

Product ID I5440
Cas No. 1224844-38-5
Purity ≥99%
Product Unit SizeCostQuantityStock
1 mg $52.90 In stock
5 mg $99.20 In stock
25 mg $286.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

INK-128 is an ATP-competitive inhibitor of mTOR, inhibiting both mTORC1 and mTORC2, protein complexes that modulate cell growth, cell survival, and cell migration. This compound displays anticancer chemotherapeutic and anti-metastatic activities in both in vitro and in vivo models. In vitro, INK-128 inhibits cell migration and adhesion, processes critical for the invasive nature of multiple myeloma; INK-128 also inhibits proliferation and decreases colony formation in an in vitro model of B-cell acute lymphoblastic leukemia. In vivo, INK-128 decreased metastases in an animal model of prostate cancer. This compound is currently in clinical trials as a potential treatment for multiple myeloma.

Product Info

Cas No.

1224844-38-5

Purity

≥99%

Formula

C15H15N7O

Formula Wt.

309.33

IUPAC Name

5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1, 3-benzoxazol-2-amine

Synonym

MLN-0128

Solubility

DMSO 62 mg/mL (200.43 mM) Ethanol 2 mg/mL (6.46 mM) Water Insoluble

Appearance

pink powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

I5440 MSDS PDF

Info Sheet

I5440 Info Sheet PDF

Brochures

PI3K-Akt-mTORC Pathway Booklet

References

Janes MR, Vu C, Mallya S, et al. Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia. 2013 Mar;27(3):586-94. PMID: 23090679.

Hsieh AC, Liu Y, Edlind MP, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012 Feb 22;485(7396):55-61. PMID: 22367541.

Maiso P, Liu Y, Morgan B, et al. Defining the role of TORC1/2 in multiple myeloma. Blood. 2011 Dec 22;118(26):6860-70. PMID: 22045983.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • D3215

    Didymin

    Flavonoid glycoside found in citrus fruit.
    ≥98%
  • T0008

    Tacrolimus

    Calcineurin inhibitor.
    ≥98%
  • T0094

    2′,7-Bisacetyltaxol

    Taxane synthesis intermediate.
    ≥98%
  • D3448

    Dimethyl Fumarate

    Fumaric acid methyl ester; nAChR agonist, indirect...
    ≥98%
  • A0965

    Adrenocorticotropic Hormone (1-14)

    Endogenous peptide hormone fragment, involved in s...
    ≥95%
  • R3011

    Recombinant TpN 15 protein

    Recombinant protein containing Treponema pallidum ...
    ≥95%
  • S9754

    Syntide 2

    Synthetic peptide, CDPK, PKC, CaMKII substrate.
    ≥95%
  • Y4802

    YM-201636

    PIKfyve inhibitor.
    ≥98%
  • H9801

    Hyaluronic Acid Sodium

    Endogenous anionic non-sulfated glycosaminoglycan,...
    ≥95%
  • A6827

    Argipressin Acetate

    Endogenous peptide, involved in vascular contracti...
    ≥95%
  • C9863

    Cyproconazole

    Triazole; 14-α demethylase inhibitor, voltage-gat...
    ≥95%
  • G8104

    Guanylin, rat/mouse

    Endogenous peptide hormone; guanyl cyclase C agoni...
    ≥95%
  • A6800

    AR-A014418

    GSK-3β inhibitor.
    ≥98%
  • D3431

    3,4-Dihydroxyphenyl Ethanol

    Polyphenol found in olive oil, antioxidant.
    ≥95%
  • P2992

    Phyllolitorin

    Peptide found in amphibian skin; GRP (BB1) and neu...
    ≥95%
  • H3277

    Histrelin Acetate

    Peptide, GnRH analog; GnRH agonist.
    ≥95%
  • C0246

    Calcimycin

    Polyether pyrrole, divalent cation ionophore.
    ≥98%
  • P9767

    Pyriproxyfen

    Juvenile insect hormone mimic.
    ≥95%
  • T0003

    T2 Tetraol

    Trichothecene mycotoxin produced by Fusarium.
    ≥97%, TLC
  • B6857

    4-Bromoflavone

    Nrf2-Keap1-ARE complex activator.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only